Login to Your Account



Financings Roundup


Friday, September 14, 2012
• Tranzyme Pharma Inc., of Research Triangle Park, N.C., agreed to sell approximately 2.6 million shares of common stock at $3.85 each in a registered direct offering seeking to raise gross proceeds of about $10 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription